Literature DB >> 36071224

Precision medicine improves outcomes in metastatic breast cancer.

.   

Abstract

Entities:  

Keywords:  Cancer; Genomics; Personalized medicine

Year:  2022        PMID： 36071224     DOI： 10.1038/d41586-022-02276-9

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  4 in total

Review 1.  Precision medicine for metastatic breast cancer--limitations and solutions.

Authors:  Monica Arnedos; Cecile Vicier; Sherene Loi; Celine Lefebvre; Stefan Michiels; Herve Bonnefoi; Fabrice Andre
Journal:  Nat Rev Clin Oncol       Date:  2015-07-21       Impact factor: 66.675

2.  A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).

Authors:  J Mateo; D Chakravarty; R Dienstmann; S Jezdic; A Gonzalez-Perez; N Lopez-Bigas; C K Y Ng; P L Bedard; G Tortora; J-Y Douillard; E M Van Allen; N Schultz; C Swanton; F André; L Pusztai
Journal:  Ann Oncol       Date:  2018-09-01       Impact factor: 32.976

3.  Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial.

Authors:  Thomas Bachelot; Thomas Filleron; Ivan Bieche; Monica Arnedos; Mario Campone; Florence Dalenc; Florence Coussy; Marie-Paule Sablin; Marc Debled; Claudia Lefeuvre-Plesse; Anthony Goncalves; Marie-Ange Mouret Reynier; William Jacot; Benoit You; Philippe Barthelemy; Benjamin Verret; Nicolas Isambert; Xavier Tchiknavorian; Christelle Levy; Jean-Christophe Thery; Tifenn L'Haridon; Jean-Marc Ferrero; Alice Mege; Francesco Del Piano; Etienne Rouleau; Alicia Tran-Dien; Julien Adam; Amelie Lusque; Marta Jimenez; Alexandra Jacquet; Ingrid Garberis; Fabrice Andre
Journal:  Nat Med       Date:  2021-01-18       Impact factor: 53.440

4.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.

Authors:  Jianfang Liu; Tara Lichtenberg; Katherine A Hoadley; Laila M Poisson; Alexander J Lazar; Andrew D Cherniack; Albert J Kovatich; Christopher C Benz; Douglas A Levine; Adrian V Lee; Larsson Omberg; Denise M Wolf; Craig D Shriver; Vesteinn Thorsson; Hai Hu
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.